Abstract:Purines could be converted into uric acid in the gut microenvironment, triggering metabolic diseases, especially gout, while the uric acid excretion is impaired. However, increasing uric acid excretion remains a challenge. In this study, we prepared a uricase‐containing intestine‐targeted explosive hydrogel microspheres via gas‐shearing microfluidics for mucosal immobilization of uricase, to realize gout inhibition through a novel transporter protein regulation pathway to accelerate the uric acid excretion for the first time. After oral administration of hydrogel microspheres, uricase could be controllably released in the intestine to hydrolyze uric acid preliminarily for hydrogen peroxide production. Once exposed in the intestinal specific catalase, hydrogen peroxide would further generate a local hyperoxic microenvironment beneficial for dopamine polymerization, thereby immobilizing uricase in intestinal mucosa finally. Through this cascade reaction, only a small amount of uricase is required for local immobilization to in‐situ up‐regulate uric acid transporter proteins of intestinal epithelial cells, excreting uric acid from the epithelial cells into the intestines to be excreted, lowering the systemic uric acid level. In vitro and in vivo studies confirmed the precisely intestinal delivery of dopamine and uricase through intestine‐targeted explosive microspheres. In vitro evaluation demonstrated that the uric acid level in human fecal samples from gout patients could be significantly reduced by up to 37% by the mimic mucosa‐immobilized uricase on the isolated porcine tissues. In vivo experiments in mouse hyperuricemia model and acute gouty arthritis model confirmed that microspheres could effectively accelerate intestinal uric acid excretion, effectively increasing fecal uric acid excretion by up to 27.6% and reducing blood uric acid by up to 71%. In addition, 16S ribosomal RNA sequencing showed that the microspheres optimized intestinal flora composition, with a significant increase in probiotic bacteria such as Akkermansia muciniphila and Verrucomicrobiales, and inhibited some common intestinal bacteria in gout patients such as Bacteroidetes, thereby improving intestinal homeostasis. In conclusion, we developed a unique inducing pathway via the small intestine mucosal layer in‐situ regulation to firstly realize an efficient uric acid intestinal excretion for gout therapy. This article is protected by copyright. All rights reserved

Bio-inspired Nanoenzyme for Metabolic Reprogramming and Anti-Inflammatory Treatment of Hyperuricemia and Gout

Biomimetic Integrated Nanozyme for Flare and Recurrence of Gouty Arthritis

Beneficial Properties and Mechanisms of Natural Phytochemicals to Combat and Prevent Hyperuricemia and Gout

Exploration of uricase-like activity in Pd@Ir nanosheets and their application in relieving acute gout using self-cascade reaction

M2 Macrophage Hybrid Membrane‐Camouflaged Targeted Biomimetic Nanosomes to Reprogram Inflammatory Microenvironment for Enhanced Enzyme‐Thermo‐Immunotherapy

A Novel Cascade Nanoreactor Integrating Two-Dimensional Pd-Ru Nanozyme, Uricase and Red Blood Cell Membrane for Highly Efficient Hyperuricemia Treatment

Spatial Confined Synergistic Enzymes with Enhanced Uricolytic Performance and Reduced Toxicity for Effective Gout Treatment.

Mild hyperthermia enhanced synergistic uric acid degradation and multiple ROS elimination for an effective acute gout therapy

Synthetic Biohybrids of Red Blood Cells and Cascaded‐Enzymes@ Metal–Organic Frameworks for Hyperuricemia Treatment

Multimodal smart systems reprogramme macrophages and remove urate to treat gouty arthritis

Highly tuned cobalt-doped MnO2 nanozyme as remarkably efficient uricase mimic

Development of a novel anti-inflammatory recombinant uricase with extended half-life for gout therapy

Arginine-rich peptide/platinum hybrid colloid nanoparticle cluster: A single nanozyme mimicking multi-enzymatic cascade systems in peroxisome

Immunogenicity-masking delivery of uricase against hyperuricemia and gout

Artificial Metalloenzyme‐Based Enzyme Replacement Therapy for the Treatment of Hyperuricemia

Bmk9 and Uricase Nanoparticle Complex for the Treatment of Gouty Arthritis and Uric Acid Nephropathy

Therapeutic Effect of Unmodified Gold-platinum Nanoparticles on Gouty Arthritis Via the Nrf2/HO-1 Pathway

Preparation and Application of Nanozymes with Uricase-Like Activity Based on Molecularly Imprinted Polymers.

Folic acid-modified lysozyme protected gold nanoclusters as an effective anti-inflammatory drug for rapid relief of gout flares in hyperuricemic rats

Intestine‐targeted Explosive Hydrogel Microsphere Promotes Uric Acid Excretion for Gout Therapy

Uricase and Horseradish Peroxidase Hybrid CaHPO4 Nanoflower Integrated with Transcutaneous Patches for Treatment of Hyperuricemia